LTS - Lohmann Therapy Systems
Sarah Irwin is a skilled Research and Development Chemist III currently employed at LTS - Lohmann Therapy Systems since August 2022. Prior to this role, Sarah held various positions at Tapemark from August 2017 to August 2022, advancing from R&D Analytical Chemist I to Research and Development Chemist III. In earlier experience at PPD, Sarah worked as an Associate Scientist, conducting general lab procedures and utilizing HPLC/UHPLC systems for pharmaceutical analysis from January 2015 to August 2017. Sarah began professional endeavors as a bartender during educational pursuits, working at Blue Moon, Howie's, and Coconut Joe's between 2010 and 2015. Sarah holds a Bachelor of Science in Biology with a focus on Aquatic Science from the University of Wisconsin-La Crosse, earned in 2014.
This person is not in any offices
LTS - Lohmann Therapy Systems
LTS Corp is the US-based subsidiary of Lohmann Therapie Systeme whose headquarters are in Andernach, Germany. LTS’s research and development focuses on two new technologies to complement and expand the potential of alternative drug delivery systems. In addition to the development of LTS Transdermal and LTS Oral Thin Film technologies, the company also develops innovative microneedle and the ‘active LTS Transdermal’ technology. LTS Microneedles that are long enough to penetrate the outer layer of skin but too short to irritate nerves and blood vessels. They can be used to inject active substances with larger molecules into the skin, an application that is largely pain-free. Microneedles create tiny holes in the outermost layer of skin, which significantly increases the rate at which the active substance is absorbed. LTS is currently researching a number of different microneedles made from different materials and with different gauges, designs and sizes for a wide range of applications.